The Blood Flow Shutdown Induced by Combretastatin A4 Impairs Gemcitabine Delivery in a Mouse Hepatocarcinoma

In recent clinical studies, vascular disrupting agents (VDAs) are mainly used in combination with chemotherapy. However, an often overlooked concern in treatment combination is the VDA-induced impairment of chemotherapy distribution in the tumor. The work presented here investigated the impact of bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Fruytier, Anne-Catherine, Le Duff, Cecile S., Po, Chrystelle, Magat, Julie, Bouzin, Caroline, Neveu, Marie-Aline, Feron, Olivier, Jordan, Benedicte F., Gallez, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179558/
https://www.ncbi.nlm.nih.gov/pubmed/28066252
http://dx.doi.org/10.3389/fphar.2016.00506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5179558/
https://www.ncbi.nlm.nih.gov/pubmed/28066252
http://dx.doi.org/10.3389/fphar.2016.00506

Ejemplares similares